Skip to content

ADMA Biologics ADMA Accounts Payable

Accounts Payable at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
$20.46M-19.0%
Amgen logo
AmgenAMGN
Gilead Sciences logo
Gilead SciencesGILD

Other financials

Income statement

See full
Revenue$114.5M-0.3%
Gross profit$80.8M+32.2%
Operating income$58.3M+67.1%
Net income$45.3M+68.5%
EPS (diluted)$0.19+72.7%

Balance sheet

See full
Cash & equivalents$138.2M+92.9%
Total debt$204.4M+2,055%
Total equity$390.3M+4.5%
Total assets$665.2M+30.3%

Cash flow

See full
Operating cash flow$58.2M+396%
CapEx$2.5M-45.9%
Free cash flow$55.7M+329%

Valuation

See full
Market cap$2.02B-54.5%
Enterprise value$2.08B-52.5%
P/E12.2×-9.2×
P/S-5.7×

Profitability

See full
Gross margin61.3%+8.7pp
Operating margin42.1%+9.0pp
Net margin32.4%-12.6pp
FCF margin21.2%+1.4pp

Returns & leverage

See full
Return on equity43.3%-35.2pp
Debt / equity0.5×+0.5×
Current ratio+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ADMA Biologics's accounts payable?
ADMA Biologics (ADMA) reported accounts payable of -$1.23M in Q1 2026.
How has ADMA Biologics's accounts payable changed year-over-year?
ADMA Biologics's accounts payable decreased by 968.3% year-over-year, from $142K to -$1.23M.
What does accounts payable mean?
Represents the net change in obligations to pay suppliers for goods and services received. An increase generally indicates that the company is utilizing trade credit to preserve cash, while a decrease suggests faster settlement of liabilities.